311 related articles for article (PubMed ID: 32758282)
1. Does propolis affect the quality of life and complications in subjects with irritable bowel syndrome (diagnosed with Rome IV criteria)? A study protocol of the randomized, double-blinded, placebo-controlled clinical trial.
Miryan M; Alavinejad P; Abbaspour M; Soleimani D; Ostadrahimi A
Trials; 2020 Aug; 21(1):698. PubMed ID: 32758282
[TBL] [Abstract][Full Text] [Related]
2. Effects of propolis supplementation on irritable bowel syndrome with constipation (IBS-C) and mixed (IBS-M) stool pattern: A randomized, double-blind clinical trial.
Miryan M; Soleimani D; Alavinejad P; Abbaspour M; Ostadrahimi A
Food Sci Nutr; 2022 Jun; 10(6):1899-1907. PubMed ID: 35702280
[TBL] [Abstract][Full Text] [Related]
3. The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study.
Faghih Dinevari M; Jafarzadeh F; Jabbaripour Sarmadian A; Abbasian S; Nikniaz Z; Riazi A
BMC Gastroenterol; 2023 Apr; 23(1):135. PubMed ID: 37098505
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
[TBL] [Abstract][Full Text] [Related]
5. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
Liang SB; Han M; Cheng HJ; Zhang QY; Zhang NW; Jia BY; Robinson N; Liu JP
Trials; 2022 Mar; 23(1):226. PubMed ID: 35313933
[TBL] [Abstract][Full Text] [Related]
6. Effects of Iranian propolis on renal function, prooxidant-antioxidant balance, metabolic status, and quality of life in patients with chronic kidney disease: A study protocol of an ongoing randomized, double-blind, placebo-controlled clinical trial.
Anvarifard P; Anbari M; Ostadrahimi A; Ardalan M; Ghoreishi Z
Contemp Clin Trials Commun; 2023 Aug; 34():101159. PubMed ID: 37360969
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB
Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of acupuncture in refractory irritable bowel syndrome: study protocol for a randomised controlled trial.
Zhao J; Chen M; Wang X; Ye K; Shi S; Li H; Wang J; Chen X; Ni J; Wei Q; Shi Y; Hu Y; Sun J; Li D; Liu S; Li Z; Zheng H; Yu SG
BMJ Open; 2021 Sep; 11(9):e045655. PubMed ID: 34518248
[TBL] [Abstract][Full Text] [Related]
9. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care.
Alderson SL; Wright-Hughes A; Ford AC; Farrin A; Hartley S; Fernandez C; Taylor C; Ow PL; Teasdale E; Howdon D; Guthrie E; Foy R; Ridd MJ; Bishop FL; Muir D; Chaddock M; Herbert A; Cooper D; Gibbins R; Newman S; Cook H; Longo R; Everitt H
Trials; 2022 Jul; 23(1):552. PubMed ID: 35804433
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of one-finger meditation massage on IBS-C based on the "gut-brain axis" theory: study protocol for a randomized controlled trial.
Zeng X; He J; Li X; Chen P; Zuo J; Cai X; Fan Z; Qu J
BMC Complement Med Ther; 2023 Jun; 23(1):185. PubMed ID: 37280574
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of acupuncture based on acupoint combination theory for irritable bowel syndrome: a study protocol for a multicenter randomized controlled trial.
Sun JW; Sun ML; Li D; Zhao J; Shi SH; Li HX; Liu HM; Gao JX; Hu Y; Zheng H; Wang X; Xue RD; Feng X; Yu SG; Li ZG
Trials; 2021 Oct; 22(1):719. PubMed ID: 34666815
[TBL] [Abstract][Full Text] [Related]
13. The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial.
Guo X; Xuan M; Zheng H; Qin S; Wu H; Huang S; Wen Z
Trials; 2021 Jul; 22(1):491. PubMed ID: 34311755
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double-Blinded, Randomised, Placebo-Controlled Clinical Trial.
Alt F; Chong PW; Teng E; Uebelhack R
Phytother Res; 2017 Jul; 31(7):1056-1062. PubMed ID: 28508427
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
Weerts ZZRM; Masclee AAM; Witteman BJM; Clemens CHM; Winkens B; Brouwers JRBJ; Frijlink HW; Muris JWM; De Wit NJ; Essers BAB; Tack J; Snijkers JTW; Bours AMH; de Ruiter-van der Ploeg AS; Jonkers DMAE; Keszthelyi D
Gastroenterology; 2020 Jan; 158(1):123-136. PubMed ID: 31470006
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.
Konstantis G; Efstathiou S; Pourzitaki C; Kitsikidou E; Germanidis G; Chourdakis M
Clin Nutr; 2023 May; 42(5):800-809. PubMed ID: 37031468
[TBL] [Abstract][Full Text] [Related]
19. Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial.
Pazhouh HK; Hosseini SMA; Taghipour A; Hamedi S; Noras M
Chin J Integr Med; 2020 Oct; 26(10):729-735. PubMed ID: 32623701
[TBL] [Abstract][Full Text] [Related]
20. Lipi Guben decoction in treating diarrheal irritable bowel syndrome: A study protocol for a randomized controlled trial.
Yang H; Liu X; Peng W; Chen R; Chen Y
Medicine (Baltimore); 2021 Jan; 100(3):e23887. PubMed ID: 33545956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
